The U.S. Department of Health and Human Services (HHS) has moved to ease access to six peptide injections, according to a draft notice that would allow certain compounded peptide products to be made available more broadly. The policy does not make any of the six compounds an FDA-approved drug. The change would instead create a more controlled pathway for access while questions about safety and effectiveness remain unresolved.
The six peptides covered by the draft notice include BPC-157, a compound that has drawn growing attention in wellness and biohacking circles despite limited human evidence. Supporters argue the move gives patients a more regulated alternative to unapproved products purchased online, while critics warn that easier access could outpace the science.
Read Full Article: https://www.naturalnews.com/2026-11-09-hhs-eases-access-peptide-injections-evidence-limited.html
